Supporting Reagents
Combating COVID-19 is of very high importance. At each step of the viral life cycle, targets must be found to disrupt and degrade the SARS-CoV-2 virus. We offer a wide range of recombinant viral proteins - including SARS-CoV-2 mutations proteins - as well as antibodies, kits and peptides. Visit our COVID-19 resource page for more information.
Below you will find high-quality supporting reagents and tools that you can use for your research on COVID-19: secondary antibodies, cytokine and inflammation arrays and other products.
Secondary Antibodies
Goat anti-rabbit:
- (31)
- (3)
- (1)
- (31)
- (2)
- (1)
- (3)
- (5)
- (3)
Rabbit anti-Human:
- (1)
- (2)
Mouse anti-Human:
- (4)
- (1)
- (1)
- (1)
- (1)
Arrays for Monitoring the Cytokine Storm
(Membrane)
- (128)
- (1)
(Membrane)
- (53)
- (1)
(Membrane)
- (40)
- (1)
Human COVID-19 Samples for Research Use
antibodies-online is able to offer you human COVID-19 samples. All serum and plasma products are whole blood derived products. Samples were collected through an IRB-approved protocol with full donor consent, and COVID-19 status has been confirmed via SARS-CoV-2 IgG antibody assay and/or PCR positive test results, respectively confirmed via SARS-CoV-2 IgG antibody assay through negative pre- trial blood draw results and positive post booster tests.
| Human SARS-CoV-2 Positive Plasma | Whole blood derived product processed using EDTA as the anticoagulant. |
| Human SARS-CoV-2 Positive Serum | Whole blood derived product. |
| Human SARS-CoV-2 Presumptive Non-Placebo Vaccine Positive Plasma | Whole blood derived product. |
| Human SARS-CoV-2 Presumptive Non-Placebo Vaccine Positive Serum | Whole blood derived product. |
| Human SARS-CoV-2 Negative Serum | Suitable for use as a negative control and to confirm serological assay results, among other research applications. |
MERS-Coronavirus Proteins
Coronavirus OC43 Spike Protein
Master of Science in engineering. 12+ years of experience in marketing and e-commerce in the life science sector.
Go to author page
